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Abstract
Adipose-derived cytokines play a prominent role in mediating the metabolic consequences of obesity
and excess body fat. Given this, we hypothesized that alterations in adipose tissue stores incurred
with exercise training would be reflected in changes in systemic cytokine concentrations. The Studies
of Targeted Risk Reduction Intervention through Defined Exercise (STRRIDE), where pronounced
changes in adipose tissue stores were observed in the absence of significant changes in dietary intake,
provided an ideal setting in which to test this hypothesis. Participants were randomized to six months
of inactivity or one of three types of aerobic exercise training regimens: low-amount-moderate-
intensity, low-amount-vigorous-intensity, and high-amount-vigorous-intensity. Plasma samples
were collected at baseline and two weeks after cessation of six months of exercise training or
inactivity. In 189 participants, concentrations of seventeen cytokines were measured using Bio-Plex
Cytokine Assays (BioRad, CA); ten additional cytokines were measured in sixty of these subjects.
Of all cytokines tested, the only concentration changes that approached statistical significance were
those for granulocyte monocyte-colony stimulating factor and vascular endothelial growth factor,
which appeared to increase with training in the low-amount-high-intensity group only (P<0.05 for
both cytokines). No response to exercise training was noted for any additional cytokine in any of the
groups. No relationships were observed between changes in cytokine concentrations and changes in
fat mass or other measures of body habitus. In contradiction to our hypothesis, despite significant
alterations in body composition, exercise training produced limited cytokine responses.
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Introduction
The growing epidemic of obesity has promoted increased interest in the role of adipose-derived
and systemic inflammatory markers in mediating the metabolic consequences of excess body
fat. Adipose tissue and adipocytes have been shown to directly express or secrete a number of
inflammatory mediators, often referred to as adipokines (reviewed in [1] and highlighted in
Table 1). Additionally, observational studies show that obesity is associated with elevated
concentrations of a number of inflammatory proteins (reviewed in [2]).
Given these relationships between inflammatory mediators and adipose tissue stores, a number
of investigations have attempted to determine if significant loss of fat mass induces a
concomitant change in the systemic concentrations of inflammatory mediators. In the context
of loss of fat mass induced via liposuction, such investigations have produced conflicting
reports of alterations, or a lack thereof, in systemic concentrations of inflammatory markers
[3,4]. Additionally, both diet-induced weight loss[5] as well as combined caloric restriction
and exercise interventions[6] appear to reduce concentrations of several inflammatory markers.
However, while exercise training is recognized as a means for significantly improving body
composition, there are a limited number of randomized, controlled studies performed in the
absence of concomitant dietary modifications to lose weight or achieve a “healthier” diet such
that the independent effects of exercise on inflammatory mediators can be assessed. Since
multiple inflammatory markers have been implicated in adipose tissue metabolism (as
reviewed in [1] and [2]), we hypothesized that an exercise training intervention that has been
shown to produce changes in adiposity[7] and anthropomorphic measures[8] in the absence of
changes in dietary intake would induce significant modulation in systemic concentrations of
these cytokines and inflammatory mediators.
Methods
Study Design
This work is a secondary analysis of the Studies of Targeted Risk Reduction Through Defined
Exercise (STRRIDE). Detailed descriptions of the study design including subject recruitment,
randomization, exercise training, and outcome variable measurements are published elsewhere.
[9] Relevant institutional review boards approved the research protocol, and informed consent
was obtained.
Subjects
Inclusion criteria were inactivity (not participating in regular exercise three or more times per
week and with a peak VO2 of less than 40 ml/kg/min), overweight to mild obesity (BMI 25 to
35 kg/m2), dyslipidemia (LDL-cholesterol of 130 to 190 mg/dl or HDL-cholesterol < 40 mg/
dl for men and < 45 mg/dl for women), post-menopausal status for women, and age between
40 and 69. Exclusion criteria included cigarette smoking, the use of medications known to
affect carbohydrate or lipid metabolism (including insulin, oral anti-diabetic agents, HMG CoA
reductase inhibitors or statins, fibric acid derivatives, bile acid sequestrants, and nicotinic acid),
participation in a dietary regimen designed to induce weight loss, presence of diabetes mellitus
(fasting glucose > 140 mg/dl), hypertension (BP > 160/90 mmHg), known cardiovascular
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disease, or a musculoskeletal condition that would prohibit exercise training. Persons using
hormone replacement therapy or routinely consuming alcoholic beverages were not excluded.
Exercise Training
Subjects were randomized to six months of continued inactivity or one of three aerobic exercise
groups: low-amount-moderate-intensity (caloric equivalent of approximately 12 miles/week
or 1200 kcal/week at 40 to 55% peak VO2), low-amount-vigorous-intensity (caloric equivalent
of approximately 12 miles/week or 1200 kcal/week at 65 to 80% peak VO2), or high-amount-
vigorous-intensity (caloric equivalent of approximately 20 miles/week or 2000 kcal/week at
65 to 80% peak VO2). Subjects randomized to exercise completed a two to three month ramp
period in order to minimize musculoskeletal injuries prior to the six months of prescribed
training. The present study is based upon 189 subjects that completed six months of prescribed
training (or continued inactivity) and had fasting plasma available from both pre- and post-
training time points. Subject flow through STRRIDE has been previously published.[10]
Exercise training was supervised, and adherence was calculated as the number of minutes that
the individual exercised in the prescribed heart rate range, recored by a heart rate monitor (Polar
Electro), divided by the number of minutes prescribed according to intervention group.
Subjects were counseled to maintain dietary intake unchanged throughout the study. Dietary
stability was confirmed with three-day food records and 24-hour dietary recall interviews
performed at baseline, at numerous time points during the intervention, and at the conclusion
of the study.
Fitness, body composition, lipid, and insulin action measurements
Clinical outcomes were evaluated at baseline (prior to ramp period) and after six months of
inactivity or prescribed exercise training. Body mass was measured also after two weeks of
detraining. Body composition and adiposity measurements were performed as previously
described.[8] Visceral adiposity and subcutaneous adiposity were measured with a single slice
abdominal CT scan at the L4 vertebra[9,11]. Fat mass was calculated as mass in kilograms x
percent body fat as determined with skinfold caliper measurements.
Fasting plasma samples were collected at baseline, after six months of continued inactivity or
exercise training and again after two weeks of training cessation for all subjects. Fasting plasma
samples were obtained two weeks after cessation of training in order to assess the sustained
effects of exercise-induced reduction in body fat rather than the acute effects of exercise. Since
we did not expect any significant changes in body habitus during the two weeks following
training cessation, using this plasma collection allowed us to obtain the best estimates of the
relationships between body habitus and inflammatory mediators at a time point distant from
the last bout of exercise, but yet early enough to avoid changes in body composition. This
strategy permitted us to assess the sustained effects of long term exercise training at a time
point sufficiently distant from the last bout of exercise to avoid the confounding acute effects
of the last bout on inflammatory cytokines. All samples were stored at ?80°C until analysis.
Cytokine measurements
In 189 subjects (88 women, 101 men) that completed six months of prescribed training (or
continued inactivity) and had fasting plasma available from both pre- and post-training time
points, seventeen cytokines concentrations were determined using Bio-Plex Cytokine Assays
(171-A11171 and 171-A11127, Biorad, Hercules CA) according to manufacturer directions.
Ten additional cytokines were measured in a smaller subject subset [n=60, (29 women, 31
men)].
Samples were diluted 1:2 and incubated overnight at 4°C. A standard range of 0?3200 pg/ml
was used. Due to concern for plate to plate variation in cytokine concentrations, all pre- and
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post- cytokine concentrations were measured on a single plate, and data were analyzed as
percent change as described below. Cytokine concentrations which were below the assay
detection limits were treated as missing values. For all cytokines, the manufacturer reported
inter- and intra-assay coefficients of variation of less than 10% and sensitivities, as defined as
lower limits of detection, of less than 10pg/ml. High sensitivity C-reactive protein (hsCRP)
was measured as previously described.[10]
Data Analysis
Descriptive statistics were calculated for each variable. The percent change in cytokine
concentration and other variables was calculated as follows: [(Post-training cytokine
concentration-Baseline cytokine concentration)/Baseline cytokine concentration)*100]. Since
changes scores were highly skewed, group differences were assessed with a nonparametric
analysis of variance using a Dunn’s post-hoc test. Pearson product correlations were performed
to assess relationships between changes in cytokine concentrations and changes in other
variables. For all statistical testing, statistical significance was established at P<0.05.
Nonparametric ANOVAs were performed with Prism 4 (GraphPad, San Diego, CA), and all
other statistics were performed using SAS Version 8.2 Enterprise Guide (SAS, Cary, NC).
Power estimations were derived for each of the 27 cytokines assuming normally distributed
data, which provides an approximation of at least 86% of power associated with rank-based
data [12].
Results
The significant improvements in body composition and adiposity we observed in response to
exercise training, as well as baseline demographic and metabolic parameters and adherence
rates, have been previously reported for the entire STRRIDE subject population.[7,8,13,14]
Relative to a slight increase in the fat mass (mean ± standard deviation relative change in fat
mass) in the inactive control group (0.5 ± 10.6%), in each of the exercise groups reported on
in this paper, we observed a significant reduction in mean fat mass (low-amount-moderate
intensity: ?5.7±10.9%; low-amount-vigorous intensity: ?7.2 ± 10.7%; high-amount-vigorous
intensity: ?13.1 ± 10.4%; P <0.0001, post-hoc P <0.05 for each exercise group versus control).
Corresponding to absolute reductions in fat mass of 1.7, 2.1, and 3.7 kg, respectively, these
changes in body fat mass occurred in the absence of any clinically or statistically significant
changes in reported caloric intake. The mean daily caloric intake change for each group was
as follows: inactive ?17 ± 499 kcal/d; low-amount-moderate intensity ?132 ± 604 kcal/d; low-
amount-vigorous intensity 189 ± 627 kcal/d; high-amount-vigorous intensity ?36 ± 525 kcal/
d (P <0.33). The mean adherence rates for each exercise group were as follows: low-amount-
moderate intensity 89.0 ± 14.2%; low-amount-vigorous intensity 92.7 ± 10.7%; high-amount-
vigorous intensity 84.4 ± 13.3%. Of the 88 female participants, 46 (52%) reported using
hormone replacement therapy.
Changes in median cytokine and hsCRP concentrations are shown in Table 1. Of the twenty-
eight molecules analyzed, only changes in granulocyte monocyte-colony stimulating factor
(GM-CSF) and vascular endothelial growth factor (VEGF) were found to be significantly
different among groups after post-hoc testing. Of note, GM-CSF concentrations were
undetectable in 44% of the subjects. Relative to the inactive group, the low-amount vigorous
intensity exercise group showed increases in GM-CSF (P <0.01) and VEGF (P <0.05)
concentrations. Using within group analyses, we observed that GM-CSF concentrations
increased with exercise training in the low-amount- moderate intensity groups and low-
amount-vigorous intensity group (P <0.05). An increase in VEGF concentrations was also
detected in the low-amount-vigorous intensity training group (P <0.05).
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Since adipose tissue is known to produce a number of systemic cytokines with metabolic effects
and given the changes in body habitus observed with exercise training, we expected to find
that changes in cytokine concentrations to be related to changes in body composition. However,
we did not find a relationship between changes in any cytokine concentration and alterations
in body fat mass (P >0.05 for all). Additionally, cytokine concentration changes were not
related to changes in total body mass, subcutaneous adiposity, visceral adiposity, minimal waist
circumference, or percent body fat as determined with skin fold caliper measurements (P >0.05
for all).
Power of the study
While criteria regarding the clinical relevance of cytokine concentration changes are lacking,
we believe that clinically relevant cytokine concentrations changes are likely to be on the order
of several times. Alterations in cytokine concentrations of such magnitudes have been observed
in low grade-inflammatory conditions such as obesity[15,16] and dementia[17]. Additionally,
for many cytokines, differences between healthy controls and recognized inflammatory
conditions such as relapsing polychondritis and rheumatoid arthritis have been reported to be
several hundred fold[18]. Based on the smallest group size of 42, at an alpha error of 0.05, we
had greater than 90% power to detect a one to three times difference for most of the cytokines
analyzed; the only exceptions to this degree of power were for the ten cytokines analyzed in
only sixty subjects, eotaxin, and interleukin- (IL) 12.
Discussion
We describe the first broad evaluation of cytokine responses in a randomized, controlled
exercise intervention that excluded concomitant dietary modifications to lose weight. Despite
producing significant beneficial changes in fat mass and body habitus, exercise training alone
evoked minimal or no responses in systemic cytokine concentrations. These findings support
those from a previously reported randomized controlled trial wherein, after 14 weeks of
exercise at 65?70% peak VO2, no significant changes were observed for adiponectin, CRP,
leptin, tumor necrosis factor alpha (TNF-?), resistin, or IL-6 (measured 48 hours after the last
bout of exercise) [19]. Similarly, a randomized, controlled trial comparing exercise training
and caloric restriction to a healthy lifestyle also demonstrated minimal alterations in TNF-? or
adiponectin (measured 48 hours after the last exercise bout)[20]. Our work demonstrates a lack
of sustained change in a number of additional classical cytokines, chemokines and growth
factors following exercise training alone. In sum, these results imply that metabolic changes
induced by exercise training occur independent of sustained alterations in the systemic levels
of inflammatory mediators, even in the face of a reduction in adiposity.
We observed that despite a mean reduction of adipose tissue mass by 9 ± 11% (or 2.5 ± 3.0
kg), exercise training did not alter cytokine concentrations to any significant degree.
Additionally, there was no relationship between change in fat mass, or any body composition
measure, and change in concentration of any cytokine. While much larger reductions in adipose
tissue mass might produce more measurable and sustained responses in circulating
concentrations of adipokines and cytokines, our findings in the setting of moderate, yet
significant, reductions of adipose tissue mass prompt us to propose that cytokine changes
previously observed with weight loss[3,5,6] are not directly related to changes in adipose tissue
mass and are not sustained. One group recently demonstrated that, when induced by diet and
exercise, weight loss produced cytokine concentration changes that were transient during the
period of weight loss, but lost after a subsequent two week period of weight maintenance.
[21] Similarly, others have shown that while changes in BMI were related to changes in TNF-
? and changes in soluble TNF-? receptors after six months, this relationship did not persist
after 18 months of an exercise and/or diet intervention.[5] Thus, since they are not sustained
Huffman et al. Page 5
Metabolism. Author manuscript; available in PMC 2009 April 1.
N
IH
-P
A
 A
uthor M
anuscript
N
IH
-P
A
 A
uthor M
anuscript
N
IH
-P
A
 A
uthor M
anuscript
during a maintenance phase of an exercise or dietary weight-loss intervention, systemic
cytokine concentration changes appear unrelated to changes in the mass of adipose tissue per
se; additionally, these and our findings lead us to speculate that cytokine concentration
alterations previously reported [3,5,6] may be more directly linked to the rate of change in
adipose tissue. While not directly tested in this investigation, our observations are consistent
with this paradigm.
Our observation that there was no change in cytokine concentrations with exercise training
confirm and extend those from similar investigations. In addition to those investigations
described above[19,20], one other study showed that four weeks of combined aerobic and
resistance training performed in the setting of constant caloric intake produced changes in
percent body fat, fitness, and insulin action, but no change was observed in IL-10 or IL-6
concentrations.[22] Similarly, a randomized, controlled intervention in older adults with
osteoarthritis found that, in the absence of a controlled dietary intervention, six months of
exercise training reduced body mass by 3.5 kg but did not significantly impact concentrations
of IL-6 and TNF-?.[5] In contrast, in the context of uncontrolled observational and cross-
sectional interventions, physical activity has been related to reduced inflammatory burden
(reviewed in[2]). Thus, the lack of change in cytokine concentrations with exercise training
observed in controlled interventions emphasizes that randomized, controlled interventional
studies are the best means of determining observational associations are causative, correlative
or chance observations.
Nonetheless, the dynamic response of cytokines to acute bouts of exercise and with exercise
training appears complex. One limitation of our investigation is that we evaluated cytokine
changes based on a single time point after completion of training. A recent nonrandomized,
but diet-controlled, 14 week exercise intervention demonstrated reductions in visceral
adiposity and IL-6, but not C-reactive protein or plasminogen activator inhibitor-1, when
plasma was collected four days after the last bout of exercise[23]. In the current investigation,
we can not confirm that cytokine concentrations were not similarly reduced earlier in the course
of training or the detraining time period, but our findings do indicate that any reduction in IL-6
concentrations is not sustained at two weeks after the last bout of exercise. Thus, we suggest
that the reader be aware of the timing of the last exercise bout relative to sample acquisition
when evaluating investigations of exercise training-induced responses in cytokines.
An additional complexity in measuring cytokine responses to exercise is that responses might
differ with respect to the underlying level of inflammation in the population studied. Our focus
was on individuals at moderate risk for cardiovascular disease as reflected by a median baseline
hsCRP of 2.1 mg/L. However, as noted in one investigation where exercise training reduced
concentrations of hsCRP in only subjects with baseline concentrations greater than 3mg/L,
[24] in populations with higher degrees of baseline inflammation, exercise training might
produce observable reductions in inflammatory markers. An additional limitation of our
investigation is an inability to account for a number of potential confounders which might
influence baseline cytokine concentrations as well as responses of these concentrations to
exercise training. These include, but are not limited to, genetic determinants, alcohol use, and
hormone replacement therapy use.
Additionally, our use of a multiplex assay system should be recognized as a methodological
difference when comparing our findings to those that have used individual cytokine assays
with lower limits of detection. Specifically, the reported percent changes, medians, and inter-
quartile ranges might not be directly comparable. As manufacturers develop increasingly
sensitive assays over time, particular attention should be paid to assay specifications when
comparing results across studies. For example, the manufacturer used in this report now offers
a “high sensitivity” cytokine multiplex assay, not available at the time this work was performed,
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that provides limits of detection of less than 1 pg/ml for all cytokines. Also, we recognize that
we did not determine coefficients of variation for the cytokine measurements. As stated above,
the manufacturer of this commercially available array system reported that both inter- and intra-
assay coefficients of variation are less than 10%. Nonetheless, by analyzing these data as
percent change, we limited the impact of inter-assay variability on our results. Additionally,
these bead-based assays rely on a minimum of 100 beads per sample, which should produce
nominal intra-assay coefficients of variation.
While inflammatory cytokines did not decrease with exercise training, we found that
concentrations of GM-CSF and VEGF increased with low-amount-vigorous intensity exercise
only. Relative to low-amount-moderate intensity and high-amount-vigorous intensity exercise
groups, we have found the low-amount-vigorous intensity exercise group to have a less robust
improvement in insulin sensitivity[13] and a trend towards less robust improvements in waist
circumference[8] and subcutaneous adipose tissue[7]. Given these findings, the observation
that GM-CSF and VEGF increases did not follow a dose response to exercise training, the
ability to measure GM-CSF concentrations in only 56% of subjects, and the large number of
cytokines evaluated in this investigation, we believe these results require significant validation
in other cohorts before they can be accepted as other than chance observations.
In summary, we report that despite robust improvements in adiposity and ectopic (visceral) fat
mass, exercise training produced limited changes in systemic concentrations of cytokines.
These findings support emerging evidence that systemic cytokine concentrations changes are
not directly related to absolute changes in amount of adipose tissue but, rather, may be more
likely related to the rate of change in adipose tissue mass. Testing such a hypothesis is worthy
of future randomized intervention studies.
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Table 1
Systemic Cytokine Baseline Concentrations and Percent Changes with Exercise Training*
Inactive Low Amount-
Moderate Intensity
Low Amount-
Vigorous Intensity
High Amount-
Vigorous Intensity
Total n 50 42 49 48
Women n 27 20 23 18
Men n 23 22 26 30
Pro-inflammatory
IL-6 17.2 (9.8, 41.7) 27.3 (11.8, 41.7) 26.7 (11.8, 56.8) 31.9 (13.8, 63.0)
ᒚ ?7.9 (?26.0, 15.3) 18.3 (?10.0, 63.5) 22.4 (?42.3, 84.1) 5.9 (?25.7, 40.8)
IL-8 2.8 (1.7, 4.7) 1.9 (1.1, 2.8) 1.9 (1.4, 3.1) 2.0 (1.2, 3.1)
ᒚ 4.5 (?20.8, 22.0) 6.0 (?25.9, 52.3) 24.3 (?31.0, 85.6) ?16.3 (?37.4, 45.7)
TNF-? 12.3 (3.9, 26.4) 3.1 (1.6, 8.5) 4.6 (2.7, 8.0) 5.0 (3.1, 10.7)
ᒚ ?13.3 (?39.1, 54.4) ?4.9 (?31.6, 36.6) ?5.1 (?42.3, 63.1) ?15.4 (?42.9, 24.3)
IL-1?¶ 3.4 (1.8, 6.5) 1.7 (0.9, 3.3) 1.8 (1.0, 5.5) 2.4 (1.4, 7.5)
ᒚ ?7.0 (?31.5, 20.6) 9.2 (?27.2, 31.8) 25.7 (?25.4, 42.4) ?24.6 (?48.3, 28.6)
MCP-1 27.7 (20.5, 37.7) 22.4 (14.9, 28.7) 24.9 (10.9, 33.9) 18.8 (11.2, 33.1)
ᒚ ?5.6 (?24.2, 9.5) ?9.4 (?28.2, 23.5) 3.5 (?32.5, 50.1) ?6.4 (?30.0, 35.9)
MIP-1? 30.9 (15.6, 42.1) 18.9 (5.9, 28.1) 23.4 (8.4, 45.5) 16.8 (7.9, 28.0)
ᒚ ?3.9 (?18.0, 14.3) 1.8 (?37.3, 55.7) 25.1 (?54.7, 100.7) ?4.2 (?41.7, 39.0)
IL-15§ 5.1 (2.2, 8.8) 2.1 (1.2, 2.5) 2.1 (1.8, 2.5) 4.0 (1.0, 30.8)
ᒚ ?14.5 (?37.9, 29.4) 10.0 (?1.5, 58.7) 14.6 (6.3, 48.7) 25.9 (?1.8, 58.0)
Eotaxin§ 100.3 (72.5, 172.3) 116.5 (82.0, 124.0) 90.8 (60.2, 130.7) 78.0 (71.1, 622.2)
ᒚ ?6.2 (?19.4, 11.6) ?3.4 (?23.3, 9.1) ?14.0 (?20.0, ?6.3) ?2.9 (?20.3, 12.7)
MIP-1?§ 5.8 (3.7, 9.07) 4.0 (2.6, 8.1) 2.4 (1.5, 9.7) 5.5 (4.1, 13.8)
ᒚ 7.0 (?20.6, 40.1) ?11.5 (?42.6, 6.5) 38.2 (7.9, 355.8) ?23.6 (?47.0, 1.3)
RANTES§ 498.6 (349.8, 711.2) 1016.5 (587.4, 1410.3) 939.8 (712.2, 1319.0) 835.9 (720.7, 2558.0)
ᒚ ?0.9 (?7.7, 4.2) 19.9 (?34.0, 125.5) 53.6 (12.8, 68.1) 7.3 (?46.8, 58.0)
VEGF§ 17.6 (9.8, 25.6) 6.5 (5.0, 10.4) 7.7 (5.7, 8.7) 9.9 (6.0, 14.4)
ᒚ 4.0 (?21.2, 16.8) 29.4 (?12.0, 97.5) 111.3†‡ ?17.1 (?29.9, ?4.1)
hsCRP 2.1 (1.2, 4.6) 2.1 (1.1, 4.6) 2.1 (1.1, 3.4) 1.5 (0.8, 3.2)
ᒚ 19.8 (?16.4, 46.0) 12.1 (?41.4, 55.9) ?8.3 (?34.6, 32.8) 3.8 (?23.0, 57.6)
8.61 (4.1, 22.3) 4.4 (2.1, 6.7) 4.6 (1.5, 6.3) 4.9 (1.8, 14.2)
IL-2¶ ?18.5 (?32.2, 9.4) 40.0 (?21.7, 206.3) 0 (?53.8, 162.0) ?21.5 (?40.2, 40.9)
GM-CSF¶ 49.2 (26.7, 112.5) 27.7 (9.4, 49.7) 18.4 (9.1, 29.1) 47.7 (9.9, 73.9)
ᒚ ?19.5 (?59.5, 11.1) 44.3† (?21.2, 110.0) 67.5†‡ (7.9, 355.6) ?23.2 (54.2, 41.5)
IFN-? 52.2 (28.1, 132.6) 15.4 (6.8, 27.7) 12.3 (4.9, 21.4) 17.2 (8.1, 31.0)
ᒚ ?11.9 (?37.3, 15.4) ?5.3 (?34.0, 45.2) 19.9 (?44.8, 164.9) ?2.6 (?34.9, 59.3)
IL-5 1.7 (1.0, 2.4) 0.9 (0.6, 2.8) 1.2 (0.7, 2.7) 1.4 (0.7, 2.9)
ᒚ ?4.5 (?27.8, 29.3) ?13.5 (?27.9, 31.4) 9.1 (?36.9, 114.5) ?13.0 (?32.5, 22.4)
IL-7 2.3 (1.4, 5.8) 1.1 (0.8, 2.1) 1.5 (0.9, 2.4) 1.4 (1.1, 3.2)
ᒚ 0 (?31.4, 28.6) 22.8 (?20.3, 68.2) 22.0 (?20.7, 61.8) ?11.6 (?34.3, 26.4)
IL-12¶ 3.9 (2.4, 12.2) 2.4 (1.3, 3.5) 1.9 (0.7, 9.2) 2.5 (1.8, 6.0)
ᒚ ?21.4 (?63.6, 38.1) 8.5 (?5.4, 22.5) ?8.2 (?88.4, 72.0) ?18.5 (?55.9, 46.2)
IL-13 2.6 (1.6, 4.3) 2.6 (1.1, 6.2) 2.7 (1.4, 9.0) 4.5 (2.1, 8.7)
ᒚ ?12.1 (?25.6, 38.1) 3.9 (?41.6, 46.8) 26.0 (?31.9, 144.5) ?14.3 (?44.9, 17.0)
IL-17¶ 3.8 (1.8, 6.4) 2.4 (0.6, 7.7) 3.6 (1.8, 5.9) 2.6 (1.4, 6.8)
ᒚ 8.3 (?35.7, 71.2) 15.1 (?34.0, 146.1) 15.3 (?42.9, 173.9) ?23.1 (?44.8, 51.9)
12.6 (3.1, 23.7) 71.5 (24.9, 72.6) 2.0 (0.2, 3.8) 8.3 (3.0, 15.9)
IL-9¶§ 31.7 (?39.3, 54.0) ?42.5 (?67.2, ?6.7) 1971.0 (?28.7, 3970.8) 15.9 (?35.3, 53.2)
G-CSF 30.3 (22.0, 44.6) 14.9 (7.4, 26.1) 13.5 (5.4, 21.9) 17.1 (6.9, 25.7)
ᒚ ?10.6 (?32.3, 14.3) ?1.0 (?32.7, 50.3) 30.1 (?28.5, 150.6) ?8.7 (?38.5, 37.7)
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Inactive Low Amount-
Moderate Intensity
Low Amount-
Vigorous Intensity
High Amount-
Vigorous Intensity
FGF basic§ 27.8 (17.8, 44.8) 14.6 (4.9, 27.6) 19.3 (12.4, 25.5) 17.1 (12.9, 26.5)
ᒚ ?3.5 (?33.4, 24.1) ?16.5 (?31.9, 28.1) 20.6 (16.2, 40.5) ?23.8 (?36.2, 4.3)
IP-10§ 520.4 (371.8, 703.0) 811.1 (712.6, 1217.5) 1094.2 (716.4, 1299.4) 821.2 (777.0, 1134.4)
ᒚ ?0.5 (?21.1, 14.2) ?8.4 (?25.6, 15.5) ?23.0 (?43.1, 0.45) 15.6 (?11.4, 41.3)
PDGFbb§ 317.6 (93.2, 927.6) 100.6 (41.7, 194.4) 21.8 (9.0, 75.9) 66.6 (29.0, 312.3)
ᒚ ?2.8 (?55.2, 80.9) ?28.3 (?78.9, 190.7) 396.5 (9.9, 3673.0) ?10.0 (?50.2, 478.7)
Anti-Inflammatory
IL-1ra§ 217.4 (136.3, 388.7) 97.7 (77.7, 191.1) 83.0 (70.4, 121.7) 146.8(93.4, 807.7)
ᒚ ?4.6 (?23.2, 6.5) 3.0 (?27.8, 23.7) 33.5 (?12.1, 121.2) 2.9 (?3.9, 20.4)
IL-10 3.8 (2.1, 7.8) 2.6 (1.1, 3.7) 2.7 (1.7, 7.6) 3.4 (2.2, 10.1)
ᒚ ?1.4 (?31.5, 36.9) 21.5 (?22.8, 80.5) 28.8 (?29.6, 99.5) ?6.0 (?25.6, 25.0)
IL-4¶ 1.18 (0.4, 2.6) 0.5 (0.2, 1.8) 1.9 (0.2, 4.1) 1.2 (0.5, 4.8)
?5.2 (?43.8, 32.0) 40.0 (?28.0, 177.3) 20.9 (?48.1, 143.8) ?13.8 (?54.8, 0.5)
*
Data are presented as median concentration (pg/ml for cytokines and mg/L for hsCRP) and median percent change (from baseline). Numbers in parenthesis
represent lower and upper quartiles for baseline concentration and percent changes, respectively. Abbreviations: IL= interleukin, TNF-? = tumor necrosis
factor-?, MCP-1 = monocyte chemoattractant protein-1, MIP-1? = macrophage inflammatory protein 1?, MIP-1? = macrophage inflammatory protein
1?, RANTES = Regulated on Activation, Normal T-cell Expressed and Secreted, VEGF = vascular endothelial growth factor, hsCRP = high sensitivity
C-reactive protein, GM-CSF= granulocyte monocyte colony stimulating factor, IFN-? = interferon-?, G-CSF = granulocyte-colony stimulating factor,
FGF basic = fibroblast growth factor basic, IP-10 = interferon-inducible protein-10, PDGFbb= platelet derived growth factor bb, IL-1ra = IL-1 receptor
antagonist. Those listed in bold have been shown to be secreted by adipose tissue and/or associated with obesity.[1,2,25-28]
ᒷ
P<0.05 for within group comparisons.
ᒸ
P<0.05 for between group comparisons; relative to the Inactive group after post-hoc testing.
x
Greater than 25% of subjects had undetectable concentrations of the indicated cytokines.
§
Measured in sixty subjects only: Inactive=32, Low Amount-Moderate Intensity=10, Low Amount-Vigorous Intensity=8, High Amount-Vigorous
Intensity=10.
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